GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » Debt-to-Equity

Invitro International (Invitro International) Debt-to-Equity : 0.00 (As of Jun. 2097)


View and export this data going back to 1991. Start your Free Trial

What is Invitro International Debt-to-Equity?

Invitro International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2097 was $0.00 Mil. Invitro International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2097 was $0.00 Mil. Invitro International's Total Stockholders Equity for the quarter that ended in Jun. 2097 was $0.96 Mil. Invitro International's debt to equity for the quarter that ended in Jun. 2097 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Invitro International's Debt-to-Equity or its related term are showing as below:

IVRO's Debt-to-Equity is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 0.23
* Ranked among companies with meaningful Debt-to-Equity only.

Invitro International Debt-to-Equity Historical Data

The historical data trend for Invitro International's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invitro International Debt-to-Equity Chart

Invitro International Annual Data
Trend Feb90 Feb91 Sep92 Sep93 Sep94 Sep95 Sep96
Debt-to-Equity
Get a 7-Day Free Trial - - - - -

Invitro International Quarterly Data
Sep92 Dec92 Mar93 Jun93 Sep93 Dec93 Mar94 Jun94 Sep94 Dec94 Mar95 Jun95 Sep95 Dec95 Mar96 Jun96 Sep96 Dec96 Mar97 Jun97
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - N/A - -

Competitive Comparison of Invitro International's Debt-to-Equity

For the Diagnostics & Research subindustry, Invitro International's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Invitro International's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Invitro International's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Invitro International's Debt-to-Equity falls into.


Invitro International Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Invitro International's Debt to Equity Ratio for the fiscal year that ended in Sep. 2096 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 2.1
=0.00

Invitro International's Debt to Equity Ratio for the quarter that ended in Jun. 2097 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 0.958
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Invitro International  (OTCPK:IVRO) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Invitro International Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Invitro International's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Invitro International (Invitro International) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Invitro International (OTCPK:IVRO) » Definitions » Debt-to-Equity
Comparable Companies
ASX:LSH IDTA TSXV:TELO ASX:CTE XSAT:ALPH BOM:526301 ABMC BOM:541299 BOM:526546 NGM:LIFE B XLRM TSXV:AVCR TEAR WAR:BMX XKRX:271850 TSXV:MBI.H WAR:IGN BOM:526504 BOM:516110 SGX:505
Traded in Other Exchanges
N/A
Address
330 East Orangethorpe Avenue, Suite D, Placentia, CA, USA, 92870
Website
https://www.invitrointl.com
Invitro International is a provider of non-animal testing methods. The company develops and commercializes test kits and laboratory services. Its testing technologies are designed to produce data regarding corrosivity, or ocular/dermal irritation, which correlate with animal and human test results. Its products and services include Irritection, Corrositex, and Lab Services. The company provides its products to various industries such as cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, and hazardous waste transportation. The majority of its revenue is generated from the United States and it also exports to other countries.